Pharmaceutics and Novel Drug Delivery Systems Market, Global Outlook and Forecast 2022-2028
Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.
This report contains market size and forecasts of Pharmaceutics and Novel Drug Delivery Systems in Global, including the following market information:
Global Pharmaceutics and Novel Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutics and Novel Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutics and Novel Drug Delivery Systems include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutics and Novel Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutics and Novel Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Pharmaceutics and Novel Drug Delivery Systems in Global, including the following market information:
Global Pharmaceutics and Novel Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutics and Novel Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutics and Novel Drug Delivery Systems include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutics and Novel Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutics and Novel Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
- Liposomes
- PEGylated Proteins & Polypeptides
- Polymer Nanoparticle
- Protein–drug Conjugates
- Other
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
- Hospitals & Clinic
- Cancer Treatment Centers
- Others
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen
- Teva
- Roche
- UCB (Union Chimique Belge)
- Celgene
- Merck
- Gilead Sciences
- Sanofi
- Pfizer
- Takeda
- Bausch&Lomb
- Samyang Biopharmaceuticals
- Johnson & Johnson
- TOLMAR
- Astellas
- AMAG Pharmaceuticals
- AbbVie
- Dr Reddy
- AstraZeneca
- Aspen
- Acrotech Biopharma
- TWi Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Pharmaceutics and Novel Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHARMACEUTICS AND NOVEL DRUG DELIVERY SYSTEMS OVERALL MARKET SIZE
2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pharmaceutics and Novel Drug Delivery Systems Players in Global Market
3.2 Top Global Pharmaceutics and Novel Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutics and Novel Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutics and Novel Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutics and Novel Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pharmaceutics and Novel Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Liposomes
4.1.3 PEGylated Proteins & Polypeptides
4.1.4 Polymer Nanoparticle
4.1.5 Protein–drug Conjugates
4.1.6 Other
4.2 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 Hospitals & Clinic
5.1.3 Cancer Treatment Centers
5.1.4 Others
5.2 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.3.2 US Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.3.3 Canada Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.3.4 Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.4.2 Germany Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.3 France Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.4 U.K. Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.5 Italy Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.6 Russia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.7 Nordic Countries Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.8 Benelux Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.5.2 China Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.4 South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.5 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.6 India Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.6.2 Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.6.3 Argentina Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.7.2 Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.3 Israel Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.5 UAE Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.1.4 Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.2.4 Teva Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.2.5 Teva Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.3.4 Roche Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 UCB (Union Chimique Belge)
7.4.1 UCB (Union Chimique Belge) Corporate Summary
7.4.2 UCB (Union Chimique Belge) Business Overview
7.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.4.4 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.4.5 UCB (Union Chimique Belge) Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.5.4 Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.5.5 Celgene Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.6.4 Merck Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Gilead Sciences
7.7.1 Gilead Sciences Corporate Summary
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.7.4 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.7.5 Gilead Sciences Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.8.4 Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.9.4 Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Takeda
7.10.1 Takeda Corporate Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.10.4 Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.10.5 Takeda Key News
7.11 Bausch&Lomb
7.11.1 Bausch&Lomb Corporate Summary
7.11.2 Bausch&Lomb Business Overview
7.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.11.4 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.11.5 Bausch&Lomb Key News
7.12 Samyang Biopharmaceuticals
7.12.1 Samyang Biopharmaceuticals Corporate Summary
7.12.2 Samyang Biopharmaceuticals Business Overview
7.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.12.4 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.12.5 Samyang Biopharmaceuticals Key News
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Corporate Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.13.4 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.13.5 Johnson & Johnson Key News
7.14 TOLMAR
7.14.1 TOLMAR Corporate Summary
7.14.2 TOLMAR Business Overview
7.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.14.4 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.14.5 TOLMAR Key News
7.15 Astellas
7.15.1 Astellas Corporate Summary
7.15.2 Astellas Business Overview
7.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.15.4 Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.15.5 Astellas Key News
7.16 AMAG Pharmaceuticals
7.16.1 AMAG Pharmaceuticals Corporate Summary
7.16.2 AMAG Pharmaceuticals Business Overview
7.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.16.4 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.16.5 AMAG Pharmaceuticals Key News
7.17 AbbVie
7.17.1 AbbVie Corporate Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.17.4 AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.17.5 AbbVie Key News
7.18 Dr Reddy
7.18.1 Dr Reddy Corporate Summary
7.18.2 Dr Reddy Business Overview
7.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.18.4 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.18.5 Dr Reddy Key News
7.19 AstraZeneca
7.19.1 AstraZeneca Corporate Summary
7.19.2 AstraZeneca Business Overview
7.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.19.4 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.19.5 AstraZeneca Key News
7.20 Aspen
7.20.1 Aspen Corporate Summary
7.20.2 Aspen Business Overview
7.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.20.4 Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.20.5 Aspen Key News
7.21 Acrotech Biopharma
7.21.1 Acrotech Biopharma Corporate Summary
7.21.2 Acrotech Biopharma Business Overview
7.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.21.4 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.21.5 Acrotech Biopharma Key News
7.22 TWi Pharmaceuticals
7.22.1 TWi Pharmaceuticals Corporate Summary
7.22.2 TWi Pharmaceuticals Business Overview
7.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.22.4 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.22.5 TWi Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Pharmaceutics and Novel Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHARMACEUTICS AND NOVEL DRUG DELIVERY SYSTEMS OVERALL MARKET SIZE
2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pharmaceutics and Novel Drug Delivery Systems Players in Global Market
3.2 Top Global Pharmaceutics and Novel Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutics and Novel Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutics and Novel Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutics and Novel Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pharmaceutics and Novel Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Liposomes
4.1.3 PEGylated Proteins & Polypeptides
4.1.4 Polymer Nanoparticle
4.1.5 Protein–drug Conjugates
4.1.6 Other
4.2 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 Hospitals & Clinic
5.1.3 Cancer Treatment Centers
5.1.4 Others
5.2 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.3.2 US Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.3.3 Canada Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.3.4 Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.4.2 Germany Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.3 France Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.4 U.K. Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.5 Italy Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.6 Russia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.7 Nordic Countries Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.4.8 Benelux Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.5.2 China Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.4 South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.5 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.5.6 India Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.6.2 Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.6.3 Argentina Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028
6.7.2 Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.3 Israel Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
6.7.5 UAE Pharmaceutics and Novel Drug Delivery Systems Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.1.4 Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.2.4 Teva Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.2.5 Teva Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.3.4 Roche Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 UCB (Union Chimique Belge)
7.4.1 UCB (Union Chimique Belge) Corporate Summary
7.4.2 UCB (Union Chimique Belge) Business Overview
7.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.4.4 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.4.5 UCB (Union Chimique Belge) Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.5.4 Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.5.5 Celgene Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.6.4 Merck Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Gilead Sciences
7.7.1 Gilead Sciences Corporate Summary
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.7.4 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.7.5 Gilead Sciences Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.8.4 Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.9.4 Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Takeda
7.10.1 Takeda Corporate Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.10.4 Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.10.5 Takeda Key News
7.11 Bausch&Lomb
7.11.1 Bausch&Lomb Corporate Summary
7.11.2 Bausch&Lomb Business Overview
7.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.11.4 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.11.5 Bausch&Lomb Key News
7.12 Samyang Biopharmaceuticals
7.12.1 Samyang Biopharmaceuticals Corporate Summary
7.12.2 Samyang Biopharmaceuticals Business Overview
7.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.12.4 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.12.5 Samyang Biopharmaceuticals Key News
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Corporate Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.13.4 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.13.5 Johnson & Johnson Key News
7.14 TOLMAR
7.14.1 TOLMAR Corporate Summary
7.14.2 TOLMAR Business Overview
7.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.14.4 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.14.5 TOLMAR Key News
7.15 Astellas
7.15.1 Astellas Corporate Summary
7.15.2 Astellas Business Overview
7.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.15.4 Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.15.5 Astellas Key News
7.16 AMAG Pharmaceuticals
7.16.1 AMAG Pharmaceuticals Corporate Summary
7.16.2 AMAG Pharmaceuticals Business Overview
7.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.16.4 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.16.5 AMAG Pharmaceuticals Key News
7.17 AbbVie
7.17.1 AbbVie Corporate Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.17.4 AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.17.5 AbbVie Key News
7.18 Dr Reddy
7.18.1 Dr Reddy Corporate Summary
7.18.2 Dr Reddy Business Overview
7.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.18.4 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.18.5 Dr Reddy Key News
7.19 AstraZeneca
7.19.1 AstraZeneca Corporate Summary
7.19.2 AstraZeneca Business Overview
7.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.19.4 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.19.5 AstraZeneca Key News
7.20 Aspen
7.20.1 Aspen Corporate Summary
7.20.2 Aspen Business Overview
7.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.20.4 Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.20.5 Aspen Key News
7.21 Acrotech Biopharma
7.21.1 Acrotech Biopharma Corporate Summary
7.21.2 Acrotech Biopharma Business Overview
7.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.21.4 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.21.5 Acrotech Biopharma Key News
7.22 TWi Pharmaceuticals
7.22.1 TWi Pharmaceuticals Corporate Summary
7.22.2 TWi Pharmaceuticals Business Overview
7.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Major Product Offerings
7.22.4 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue in Global Market (2017-2022)
7.22.5 TWi Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Pharmaceutics and Novel Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Pharmaceutics and Novel Drug Delivery Systems Market Drivers in Global Market
Table 3. Pharmaceutics and Novel Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Pharmaceutics and Novel Drug Delivery Systems in Global Market
Table 5. Top Pharmaceutics and Novel Drug Delivery Systems Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmaceutics and Novel Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Pharmaceutics and Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 32. Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 35. Teva Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 38. Roche Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 39. UCB (Union Chimique Belge) Corporate Summary
Table 40. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 41. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 44. Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 47. Merck Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 48. Gilead Sciences Corporate Summary
Table 49. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 50. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 53. Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 56. Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 57. Takeda Corporate Summary
Table 58. Takeda Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 59. Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 60. Bausch&Lomb Corporate Summary
Table 61. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 62. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 63. Samyang Biopharmaceuticals Corporate Summary
Table 64. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 65. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 66. Johnson & Johnson Corporate Summary
Table 67. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 68. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 69. TOLMAR Corporate Summary
Table 70. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 71. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 72. Astellas Corporate Summary
Table 73. Astellas Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 74. Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 75. AMAG Pharmaceuticals Corporate Summary
Table 76. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 77. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 78. AbbVie Corporate Summary
Table 79. AbbVie Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 80. AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 81. Dr Reddy Corporate Summary
Table 82. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 83. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 84. AstraZeneca Corporate Summary
Table 85. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 86. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 87. Aspen Corporate Summary
Table 88. Aspen Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 89. Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 90. Acrotech Biopharma Corporate Summary
Table 91. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 92. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 93. TWi Pharmaceuticals Corporate Summary
Table 94. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 95. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 1. Pharmaceutics and Novel Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Pharmaceutics and Novel Drug Delivery Systems Market Drivers in Global Market
Table 3. Pharmaceutics and Novel Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Pharmaceutics and Novel Drug Delivery Systems in Global Market
Table 5. Top Pharmaceutics and Novel Drug Delivery Systems Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmaceutics and Novel Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Pharmaceutics and Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutics and Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmaceutics and Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 32. Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 35. Teva Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 38. Roche Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 39. UCB (Union Chimique Belge) Corporate Summary
Table 40. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 41. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 44. Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 47. Merck Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 48. Gilead Sciences Corporate Summary
Table 49. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 50. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 53. Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 56. Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 57. Takeda Corporate Summary
Table 58. Takeda Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 59. Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 60. Bausch&Lomb Corporate Summary
Table 61. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 62. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 63. Samyang Biopharmaceuticals Corporate Summary
Table 64. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 65. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 66. Johnson & Johnson Corporate Summary
Table 67. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 68. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 69. TOLMAR Corporate Summary
Table 70. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 71. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 72. Astellas Corporate Summary
Table 73. Astellas Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 74. Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 75. AMAG Pharmaceuticals Corporate Summary
Table 76. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 77. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 78. AbbVie Corporate Summary
Table 79. AbbVie Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 80. AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 81. Dr Reddy Corporate Summary
Table 82. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 83. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 84. AstraZeneca Corporate Summary
Table 85. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 86. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 87. Aspen Corporate Summary
Table 88. Aspen Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 89. Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 90. Acrotech Biopharma Corporate Summary
Table 91. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 92. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 93. TWi Pharmaceuticals Corporate Summary
Table 94. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product Offerings
Table 95. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Pharmaceutics and Novel Drug Delivery Systems Segment by Type in 2021
Figure 2. Pharmaceutics and Novel Drug Delivery Systems Segment by Application in 2021
Figure 3. Global Pharmaceutics and Novel Drug Delivery Systems Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceutics and Novel Drug Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2021
Figure 8. By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 12. US Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 16. Germany Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 24. China Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Pharmaceutics and Novel Drug Delivery Systems Segment by Type in 2021
Figure 2. Pharmaceutics and Novel Drug Delivery Systems Segment by Application in 2021
Figure 3. Global Pharmaceutics and Novel Drug Delivery Systems Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceutics and Novel Drug Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceutics and Novel Drug Delivery Systems Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2021
Figure 8. By Type - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 12. US Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 16. Germany Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 24. China Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmaceutics and Novel Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
